- This event has passed.
Event Navigation
Joint workshop with BioNJ
Description
BioNJ, the life sciences trade association for New Jersey, and SAPA, the Sino-American Pharmaceutical Professionals Association, are excited to partner on “China and U.S. Collaboration: Innovation on the Horizon,” a free Webinar taking place on January 14, 2021, from 8:30 a.m.-10:30 a.m. EST.
Webinar topics include:
|
•
|
An overview of the biopharma industry in China and the U.S.
|
|
•
|
Opportunities for collaboration between China and the U.S., featuring New Jersey as a case study
|
|
•
|
The regulatory environment/process in both countries
|
|
•
|
Investor insights on doing business in China and the U.S.
|
Program Agenda:
| 8:30 a.m.-8:40 am | Welcome by BioNJ and SAPA |
| Debbie Hart, President, and CEO, BioNJ John Sun, Ph.D., President, SAPA & Global Program Lead, Novartis |
|
| 8:40 a.m.-8:50 am | New Jersey: A Leading Hub for Medical Innovation |
| Cathy Scangarella, Chief Business Development Officer, Choose New Jersey | |
| 8:50 a.m-9:00 a.m. | Biotech Market Dynamics in China |
| Brad Loncar, CEO, Loncar Investments | |
| 9:00 a.m-9:20 a.m. | The Regulatory Environment in China |
| Sara Wang, Sr. Director, Science and Regulatory, RDPAC | |
| 9:20 a.m.-9:40 a.m. | The Regulatory Environment in the U.S. |
| Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration | |
| 9:40 a.m.-10:25 a.m. | Panel Discussion: China and U.S. Collaboration: Innovation on the Horizon |
| Lu Cao, Managing Director, Corporate & Investment Bank, J.P. Morgan Echo Hindle-Yang, President and CEO, MSQ Ventures Stuart Peltz, Ph.D., CEO, PTC Therapeutics Lily Zou, Ph.D., CEO, Fosun Pharma USA |
|
| 10:25 a.m.-10:30 a.m. | Closing Remarks |
Please join us for this very important program. Click here to register for free.
Once registered, you will receive your Zoom login the week of the program. Please contact BioNJ@BioNJ.org with any questions.